Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-15 4:30 pm Purchase | 13G | SENESTECH INC PAR $0.0 SNES | Lind Global Fund II LP | 565,000 9.9% | 462,000 (+448.54%) | View |
| 2024-03-27 7:37 pm Purchase | 13G | NLS Pharmaceutics Ltd. NLSP | Lind Global Fund II LP | 4,300,000 9.9% | 4,300,000 (New Position) | View |
| 2024-03-19 4:30 pm Purchase | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | Lind Global Fund II LP | 1,250,000 5.7% | 1,250,000 (New Position) | View |
| 2024-03-06 4:24 pm Purchase | 13G | ORAGENICS INC PAR $0.001 N OGEN | Lind Global Fund II LP | 265,000 5.9% | 265,000 (New Position) | View |
| 2024-02-21 4:39 pm Purchase | 13G | BIOLASE INC PAR $.001 BIOL | Lind Global Fund II LP | 1,190,000 9.9% | 1,180,790 (+12820.74%) | View |
| 2024-02-21 4:38 pm Sale | 13G | TOUGHBUILT INDS INC PAR $. TBLT | Lind Global Fund II LP | 77,000 9.9% | -1,145,387 (-93.70%) | View |
| 2024-02-15 7:36 pm Purchase | 13G | TENAX THERAPEUTICS INC PAR TENX | Lind Global Fund II LP | 71,500 9.9% | 71,500 (New Position) | View |
| 2024-02-13 8:16 pm Purchase | 13G | WISA TECHNOLOGIES INC WISA | Lind Global Fund II LP | 30,385 0.2% | 30,385 (New Position) | View |
| 2024-02-13 8:15 pm Sale | 13G | WINDTREE THERAPEUTICS INC WINT | Lind Global Fund II LP | 290,102 5.3% | -185,000 (-38.94%) | View |
| 2024-02-13 8:15 pm Purchase | 13G | VERSUS SYS INC NO PAR VS | Lind Global Fund II LP | 275,000 9.9% | 275,000 (New Position) | View |
| 2024-02-13 8:15 pm Purchase | 13G | T2 BIOSYSTEMS INC PAR $0.0 TTOO | Lind Global Fund II LP | 20,370 0.5% | 20,370 (New Position) | View |
| 2024-02-13 8:14 pm Sale | 13G | TOUGHBUILT INDS INC PAR $. TBLT | Lind Global Fund II LP | 1,222,387 3.2% | -947,123 (-43.66%) | View |
| 2024-02-13 8:14 pm Purchase | 13G | SIYATA MOBILE INC NO PAR N SYTA | Lind Global Fund II LP | 51,242 8.6% | 51,242 (New Position) | View |
| 2024-02-13 8:13 pm Purchase | 13G | SENESTECH INC PAR $0.0 SNES | Lind Global Fund II LP | 103,000 9.9% | 103,000 (New Position) | View |
| 2024-02-13 8:13 pm Sale | 13G | SMX SEC MATTERS PLC SHS N SMX | Lind Global Fund II LP | 163,721 4.1% | -2,980,724 (-94.79%) | View |
| 2024-02-13 8:12 pm Sale | 13G | SINTX TECHNOLOGIES INC PAR SINT | Lind Global Fund II LP | 0 0% | -865,000 (Position Closed) | View |
| 2024-02-13 8:12 pm Sale | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Lind Global Fund II LP | 26,279 0.1% | -2,473,721 (-98.95%) | View |
| 2024-02-13 8:12 pm Unchanged | 13G | REVELATION BIOSCIENCES INC WT REVBW | Lind Global Fund II LP | 186,500 2.9% | 0 (Unchanged) | View |
| 2024-02-13 8:11 pm Sale | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Lind Global Fund II LP | 62,500 6% | -927,500 (-93.69%) | View |
| 2024-02-13 8:11 pm Purchase | 13G | PAXMEDICA INC PXMD | Lind Global Fund II LP | 251,770 9.9% | 251,770 (New Position) | View |